BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6430683)

  • 1. Cysteamine inhibition of prolactin immunoassayability and secretion: studies with aminothiophenols and other analogs.
    Jacobs LS; Lorenson MY
    Endocrinology; 1984 Sep; 115(3):1210-7. PubMed ID: 6430683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteamine inhibition of bovine pituitary secretory granule prolactin immunoassayability and release.
    Lorenson MY
    Endocrinology; 1984 Aug; 115(2):728-35. PubMed ID: 6745176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro conditions modify immunoassayability of bovine pituitary prolactin and growth hormone: insights into their secretory granule storage forms.
    Lorenson MY
    Endocrinology; 1985 Apr; 116(4):1399-407. PubMed ID: 3918853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine, zinc, and thiols modify detectability of rat pituitary prolactin: a comparison with effects on bovine prolactin suggests differences in hormone storage.
    Jacobs LS; Lorenson MY
    Metabolism; 1986 Mar; 35(3):209-15. PubMed ID: 3081777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of bovine pituitary prolactin by cysteamine involves a thiol:disulfide mechanism.
    Lorenson MY; Jacobs LS
    Endocrinology; 1984 Oct; 115(4):1492-5. PubMed ID: 6479100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiol regulation of depletion-transformation and release of prolactin by the pituitary of the lactating rat.
    Mena F; Clapp C; Aguayo D; Lorenson MY; Martinez-Escalera G
    Endocrinology; 1986 May; 118(5):1795-802. PubMed ID: 3698895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential interaction of [35S]cysteamine with pituitary secretory granule storage forms of prolactin.
    Lorenson MY; Jacobs LS
    Neuroendocrinology; 1988 Apr; 47(4):358-64. PubMed ID: 3374761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal by thiols of dopamine-, stalk-median eminence-, and zinc-induced inhibition of prolactin transformation in adenohypophyses of lactating rats.
    Martinez-Escalera G; Clapp C; Morales MT; Lorenson MY; Mena F
    Endocrinology; 1986 May; 118(5):1803-7. PubMed ID: 3698896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detectability of pituitary PRL and GH by immunoassay is increased by thiols and suppressed by divalent cations.
    Lorenson MY; Robson DL; Jacobs LS
    Endocrinology; 1983 May; 112(5):1880-2. PubMed ID: 6403341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of action of cysteamine in depleting prolactin immunoreactivity.
    Sagar SM; Millard WJ; Martin JB; Murchison SC
    Endocrinology; 1985 Aug; 117(2):591-600. PubMed ID: 3926458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteamine causes reduction of prolactin monomers followed by aggregation in the rat pituitary gland.
    Scammell JG; Burrage TG; Eisenfeld AJ; Dannies PS
    Endocrinology; 1985 Jun; 116(6):2347-54. PubMed ID: 3996317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmotic pressure regulation of prolactin and growth hormone release from bovine secretory granules.
    Lorenson MY; Jacobs LS
    Endocrinology; 1987 Jan; 120(1):365-72. PubMed ID: 3780568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteamine depletes prolactin (PRL) but does not alter the structure of PRL-containing granules in the anterior pituitary.
    Weinstein LA; Landis DM; Sagar SM; Millard WJ; Martin JB
    Endocrinology; 1984 Oct; 115(4):1543-50. PubMed ID: 6479101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in molecular variants during in vitro transformation and release of prolactin by the pituitary gland of the lactating rat.
    Mena F; Hummelt G; Aguayo D; Clapp C; Martínez de la Escalera G; Morales MT
    Endocrinology; 1992 Jun; 130(6):3365-77. PubMed ID: 1597148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay.
    Parsons JA; Peterson EK; Hartfel MA
    Endocrinology; 1984 May; 114(5):1812-7. PubMed ID: 6714167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cysteamine, cystamine, and the structurally related compounds taurine, N-acetyl-cysteine, and D-penicillamine on plasma prolactin levels in normal and estrogen-primed hyperprolactinemic rats.
    Scott JS; Lakin CA; Oliver JR
    Endocrinology; 1987 Aug; 121(2):812-8. PubMed ID: 3109888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divalent cation inhibition of hormone release from isolated adenohypophysial secretory granules.
    Lorenson MY; Robson DL; Jacobs LS
    J Biol Chem; 1983 Jul; 258(14):8618-22. PubMed ID: 6408091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin depleting potency of cysteamine-related thiols and amines in the rat: structure-activity relation.
    Szabo S; Reichlin S; Bollinger-Gruber JA; Brown A
    J Pharmacol Exp Ther; 1992 Nov; 263(2):752-6. PubMed ID: 1359114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 22K variant of rat prolactin: evidence for identity to prolactin-(1-173), storage in secretory granules, and regulated release.
    Anthony PK; Stoltz RA; Pucci ML; Powers CA
    Endocrinology; 1993 Feb; 132(2):806-14. PubMed ID: 8425495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteamine-induced depletion of somatostatin and prolactin.
    Millard WJ; Sagar SM; Martin JB
    Fed Proc; 1985 Jun; 44(9):2546-50. PubMed ID: 2860016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.